US 12,447,233 B2
Solid substrates for promoting cell and tissue growth
Nir Altschuler, Tsur Yitskhak (IL)
Assigned to CARTIHEAL (2009) LTD., Kfar Saba (IL)
Filed by CARTIHEAL (2009) LTD., Kfar Saba (IL)
Filed on Dec. 18, 2023, as Appl. No. 18/543,199.
Application 18/543,199 is a continuation of application No. 17/471,760, filed on Sep. 10, 2021, granted, now 11,878,090.
Application 17/471,760 is a continuation of application No. 16/837,232, filed on Apr. 1, 2020, granted, now 11,116,873, issued on Sep. 14, 2021.
Application 16/837,232 is a continuation of application No. 14/767,428, granted, now 10,806,823, issued on Oct. 20, 2020, previously published as PCT/IL2014/050141, filed on Feb. 10, 2014.
Claims priority of provisional application 61/773,228, filed on Mar. 6, 2013.
Claims priority of provisional application 61/773,219, filed on Mar. 6, 2013.
Claims priority of provisional application 61/764,467, filed on Feb. 13, 2013.
Claims priority of provisional application 61/763,985, filed on Feb. 13, 2013.
Claims priority of provisional application 61/763,981, filed on Feb. 13, 2013.
Claims priority of provisional application 61/764,496, filed on Feb. 13, 2013.
Prior Publication US 2024/0226378 A1, Jul. 11, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 27/36 (2006.01); A61F 2/28 (2006.01); A61F 2/30 (2006.01); A61L 27/12 (2006.01); A61L 27/20 (2006.01); A61L 27/38 (2006.01); A61L 27/40 (2006.01); A61L 27/50 (2006.01); A61L 27/52 (2006.01); A61L 27/54 (2006.01); A61L 27/56 (2006.01); C01B 25/32 (2006.01); C01F 11/18 (2006.01); G01N 1/00 (2006.01)
CPC A61L 27/3608 (2013.01) [A61F 2/28 (2013.01); A61F 2/30 (2013.01); A61F 2/30756 (2013.01); A61L 27/12 (2013.01); A61L 27/20 (2013.01); A61L 27/3604 (2013.01); A61L 27/3637 (2013.01); A61L 27/365 (2013.01); A61L 27/3654 (2013.01); A61L 27/3834 (2013.01); A61L 27/40 (2013.01); A61L 27/50 (2013.01); A61L 27/52 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); C01B 25/32 (2013.01); C01F 11/18 (2013.01); G01N 1/00 (2013.01); A61F 2230/0006 (2013.01); A61F 2230/0065 (2013.01); A61F 2230/0067 (2013.01); A61F 2230/0069 (2013.01); A61F 2230/0071 (2013.01); A61F 2230/0086 (2013.01); A61L 2300/112 (2013.01); A61L 2300/41 (2013.01); A61L 2300/412 (2013.01); A61L 2300/414 (2013.01); A61L 2300/426 (2013.01); A61L 2430/02 (2013.01); A61L 2430/06 (2013.01); C01P 2006/90 (2013.01)] 20 Claims
 
1. A process for selection of an optimized marine organism skeletal derivative-based solid substrate for promoting cell or tissue growth or restored function, said process comprising:
isolating or preparing a marine organism skeletal derivative-based solid material:
establishing a specific fluid uptake capacity value of said marine organism skeletal derivative-based solid material, which specific fluid uptake capacity value is determined by establishing a spontaneous fluid uptake value divided by a total fluid uptake value; or establishing a contact angle value; and
selecting a marine organism skeletal derivative-based solid material characterized by a specific fluid uptake capacity value of at least 75% or characterized by having a contact angle value of less than 60 degrees, when in contact with a fluid.